J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of...
J&J's (JNJ -0.5%) Janssen Pharmaceuticals settles with 36 states and the District of Columbia regarding allegations related to promotional and marketing practices for its anti-psychotic medication Risperdal. Under the terms of the agreement, the company will pay approximately $181M, with predesignated portions to be paid to each state participating in the settlement.
From other sites
at Financial Times (Wed, 4:54AM)
at Nasdaq.com (Mon, 11:46AM)
at Investopedia (Apr 10, 2015)
at 4-traders.com (Mar 24, 2015)
at Nasdaq.com (Mar 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs